OTC Healthcare in Brazil
Euromonitor International's OTC Healthcare in Brazil market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 133 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Positive economy indicators push sales of OTC healthcare
The positive performance of OTC healthcare in the review period was supported by a stable economy with low inflation rates, average GDP growth of more than 4%, low unemployment, appreciation of the Real against the US dollar and rising disposable incomes, which were responsible for many people migrating from socioeconomic stratum D to C. These factors played an important role in giving low-income consumers access to medicines to treat minor ailments, such as analgesics, cough, cold and allergy remedies and digestive remedies.
New rules for OTC advertising
After three year of discussions, ANVISA is expected to approve by the end of 2008 or in early 2009 new regulations restricting the advertising of medicines, including OTC products. The proposed new regulations were criticised by the OTC industry association ABIMIP and some advertising agency associations, such as ABAP (Brazilian Association of Advertising Agencies) and CONAR (Council for Self-regulation of Advertising), with claims that further restrictions on OTC advertising might impact self-medication in Brazil.
Hypermarcas acquires DM Indústria Farmacêutica and Farmasa
Hypermarcas, a large domestic consumer goods company, acquired the two manufacturers DM Indústria Farmacêutica and Farmasa – Laboratório Americano de Farmacoterapia in 2007 and 2008. Both companies have a strong position in OTC healthcare, with wide portfolios that include analgesics, digestive remedies, cough, cold and allergy remedies, and calming and sleeping products. As a result, Hypermarcas has become the second leading company in OTC healthcare, behind Sanofi-Aventis.
Further consolidation of drugstores
Parapharmacies/drugstores account for the bulk of sales of OTC healthcare, as Brazilian legislation is very strict regarding sales of medicines, which are almost entirely restricted to this outlet type. Internet retailing has slowly experienced growth, as the main drugstores chains, such as Droga Raia, Drogaria Onofre and Drogasil, have invested in this channel. Direct selling suffered a significant decline in share in the latter part of the review period, due in part to the weak performance of Herbalife in meal replacement products and dietary supplements.
Slowdown growth in the next two years
OTC healthcare is expected to witness only moderate growth in 2009 and 2010, due to recession caused by the so-called “credit crunch”. Value will, however, be sustained to some extent by unit price rises, due to the depreciation of the Real against the US dollar. Most raw materials are imported, and the weaker currency will increase input prices, and thus the retailing selling price of medicines.
Table of contents
OTC HEALTHCARE IN BRAZIL : MARKET INSIGHT
EXECUTIVE SUMMARY
Positive economy indicators push sales of OTC healthcare
New rules for OTC advertising
Hypermarcas acquires DM Indústria Farmacêutica and Farmasa
Further consolidation of drugstores
Slowdown growth in the next two years
KEY TRENDS AND DEVELOPMENTS
Further restriction to advertising of OTC products
Hypermarcas acquires two leading OTC manufacturers
Specific department for OTC products established within ANVISA
Financial crisis affects OTC products
Senior consumers and women over 40 years old attract investment
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
De-reimbursement
Advertising
Packaging and labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - BRAZIL
ACHé LABORATóRIOS FARMACêUTICOS SA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Aché Laboratórios Farmacêuticos SA: Key Facts
Summary 4 Aché Laboratórios Farmacêuticos SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 5 Aché Laboratórios Farmacêuticos SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 6 Aché Laboratórios Farmacêuticos SA: Competitive Position 2008
BAYER SA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Bayer SA: Key Facts
Summary 8 Bayer SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Bayer SA: Competitive Position 2008
BOEHRINGER INGELHEIM DO BRASIL QUíMICA E FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 12 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 13 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2008
DM INDúSTRIA FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 14 DM Indústria Farmacêutica Ltda: Key Facts
Summary 15 DM Indústria Farmacêutica Ltda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 16 DM Indústria Farmacêutica Ltda: Competitive Position 2008
EMS SA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 17 EMS SA: Key Facts
Summary 18 EMS SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 19 EMS SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 20 EMS SA: Competitive Position 2008
EUROFARMA LABORATóRIO LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 21 Eurofarma Laboratório Ltda: Key Facts
Summary 22 Eurofarma Laboratório Ltda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 23 Eurofarma Laboratório Ltda: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 24 Eurofarma Laboratório Ltda: Competitive Position 2008
JANSSEN-CILAG FARMACEUTICA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 25 Janssen-Cilag Farmacêutica Ltda: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 26 Janssen-Cilag Farmacêutica Ltda: Competitive Position 2008
MEDLEY SA INDúSTRIA FARMACêUTICA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 27 Medley SA Indústria Farmacêutica: Key Facts
Summary 28 Medley SA Indústria Farmacêutica: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 29 Medley SA Indústria Farmacêutica: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 30 Medley SA Indústria Farmacêutica: Competitive Position 2008
NYCOMED PHARMA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 31 Nycomed Pharma Ltda: Key Facts
Summary 32 Nycomed Pharma Ltda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 33 Nycomed Pharma Ltda: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 34 Nycomed Pharma Ltda: Competitive Position 2008
SANOFI-AVENTIS FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 35 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Summary 36 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 37 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2008
ANALGESICS IN BRAZIL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 15 Analgesics Company Shares by Value 2004-2008
Table 16 Analgesics Brand Shares by Value 2005-2008
Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN BRAZIL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 21 Sales of Decongestants by Type: Value 2003-2008
Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN BRAZIL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 30 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 32 Herbal vs Standard Digestive Remedies 2003-2008
Table 33 Digestive Remedies Company Shares by Value 2004-2008
Table 34 Digestive Remedies Brand Shares by Value 2005-2008
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN BRAZIL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 37 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 39 Herbal vs Standard Medicated Skin Care 2003-2008
Table 40 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 41 Medicated Skin Care Company Shares by Value 2004-2008
Table 42 Medicated Skin Care Brand Shares by Value 2005-2008
Table 43 Acne Treatments Brand Shares by Value 2005-2008
Table 44 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN BRAZIL
HEADLINES
TRENDS
Vitamins
Dietary Supplements
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 49 Folic Acid v Other B Vitamins 2004-2008
Table 50 Dietary Supplements by Positioning 2006-2008
Table 51 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 52 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 53 Vitamins Brand Shares by Value 2005-2008
Table 54 Dietary Supplements Brand Shares by Value 2005-2008
Summary 38 Dietary Supplements: Brand Ranking by Positioning 2008
Table 55 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN BRAZIL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 57 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 58 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 59 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 60 NRT Gum Flavours 2006-2008
Table 61 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 62 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 63 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN BRAZIL
HEADLINES
SECTOR DATA
Table 65 Sales of Eye Care by Subsector: Value 2003-2008
Table 66 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 67 Standard Eye Care by Type 2007-2008
Table 68 Eye Care Company Shares by Value 2004-2008
Table 69 Eye Care Brand Shares by Value 2005-2008
Table 70 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 71 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN BRAZIL
HEADLINES
SECTOR DATA
Table 72 Sales of Ear Care: Value 2003-2008
Table 73 Sales of Ear Care: % Value Growth 2003-2008
Table 74 Ear Care Company Shares by Value 2004-2008
Table 75 Ear Care Brand Shares by Value 2005-2008
Table 76 Forecast Sales of Ear Care: Value 2008-2013
Table 77 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN BRAZIL
HEADLINES
SECTOR DATA
Table 78 Sales of Adult Mouth Care: Value 2003-2008
Table 79 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 80 Adult Mouth Care Company Shares by Value 2004-2008
Table 81 Adult Mouth Care Brand Shares by Value 2005-2008
Table 82 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 83 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN BRAZIL
HEADLINES
SECTOR DATA
Table 84 Sales of Calming and Sleeping Products: Value 2003-2008
Table 85 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 86 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 87 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 88 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 89 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN BRAZIL
HEADLINES
SECTOR DATA
Table 90 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 91 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 92 Wound Treatments Company Shares by Value 2004-2008
Table 93 Wound Treatments Brand Shares by Value 2005-2008
Table 94 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 95 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013